A Phase 3 interventional study of Omeprazole/sodium bicarbonate and omeprazole magnesium (20 mg equivalent) in Gastric Acid and Human Experimentation, sponsored by Bayer. Completed. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-11.
Sponsored by Bayer · Phase 3 and Interventional
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Open-label randomized crossover design study. 60 participants will be evaluated on Day 1 to compare effects on stomach acid; 30 participants will continue treatment for 7 days and will have repeat evaluations at Day 7.
Enrolled participants were divided into 2 groups, with 30 participants in each group.
Group 1: This group was randomized into a single-dose, 2-way crossover design. These participants received single administrations (day 1 dosing only) of Zegerid OTC Capsules, and Prilosec OTC Tablets (both at a 20 mg omeprazole dose), in a 2-way randomized order, with a minimum of a 2-week washout period between treatment legs. This group underwent a 24-hour intragastric pH study on each of the 2 dosing occasions.
Group 2: This group was randomized into a 2-way crossover design in which they received 7 days administration of Zegerid OTC Capsules and Prilosec OTC Tablets, respectively. As with the prior group, there was a minimum of a 2-week washout period between treatment legs. Participants assigned to this treatment group underwent 24-hour intragastric pH recordings on the days which they received their 1st and last (7th) dose of the two treatment drugs.
In addition to the above detailed procedures, all participants (both groups) underwent a 24-hour baseline intragastric pH study prior to starting their randomized treatments. This study design enabled all 60 participants to be evaluated for effects of the first dose of Prilosec OTC Tablets and Zegerid OTC Capsules on change in intragastric pH during the subsequent 24-hour period following the first dose.
Bayer is the lead sponsor of 1,674 studies on the registry; 51 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 132 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Omeprazole 20 mg /sodium bicarbonate 1100 mg over-the-counter (OTC) Capsule
Drug: Omeprazole/sodium bicarbonate
Omeprazole magnesium 20 mg OTC tablet
Drug: omeprazole magnesium (20 mg equivalent)
Drug pages: Omeprazole · Sodium Bicarbonate
Single dose of omeprazole/sodium bicarbonate per day for either 1 or 7 days.
Also known as: Zegerid
Single dose of omeprazole magnesium per day for either 1 or 7 days.
Also known as: Prilosec OTC Tablet
Change From Baseline in Median 24-hour Intragastric pH on the 7th Day of Drug Administration
The change from Baseline in median pH was calculated as: median pH on Day 7 minus median pH at Baseline. The pH scale ranges from 0 to 14. A pH of 7 is neutral. A pH less than 7 is acidic. A pH greater than 7 is basic.
Time frame: Baseline and 7 days
| Milestone | Zegerid First, Then Prilosec (1- Day Dosing) | Prilosec First, Then Zegerid (1-Day Dosing) | Zegerid First, Then Prilosec ( 7-Day Dosing) | Prilosec First, Then Zegerid (7-Day Dosing) |
|---|---|---|---|---|
| Started | 15 | 15 | 15 | 15 |
| Completed | 15 | 15 | 15 | 15 |
| Not completed | 0 | 0 | 0 | 0 |
| Milestone | Zegerid First, Then Prilosec (1- Day Dosing) | Prilosec First, Then Zegerid (1-Day Dosing) | Zegerid First, Then Prilosec ( 7-Day Dosing) | Prilosec First, Then Zegerid (7-Day Dosing) |
|---|---|---|---|---|
| Started | 15 | 15 | 15 | 15 |
| Completed | 15 | 15 | 15 | 15 |
| Not completed | 0 | 0 | 0 | 0 |
| Milestone | Zegerid First, Then Prilosec (1- Day Dosing) | Prilosec First, Then Zegerid (1-Day Dosing) | Zegerid First, Then Prilosec ( 7-Day Dosing) | Prilosec First, Then Zegerid (7-Day Dosing) |
|---|---|---|---|---|
| Started | 15 | 15 | 15 | 15 |
| Completed | 15 | 15 | 15 | 15 |
| Not completed | 0 | 0 | 0 | 0 |
The change from Baseline in median pH was calculated as: median pH on Day 7 minus median pH at Baseline. The pH scale ranges from 0 to 14. A pH of 7 is neutral. A pH less than 7 is acidic. A pH greater than 7 is basic.
| pH scale | Zegerid | Prilosec |
|---|---|---|
| Day 7 Score | 4.575 ± 1.349 | 3.980 ± 1.433 |
| Change from Baseline in pH | 3.165 ± 1.360 | 2.550 ± 1.478 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Zegerid | — | 0/30 (0%) | 0/30 (0%) |
| Prilosec | — | 0/30 (0%) | 0/30 (0%) |
| Age, Continuous(years) | Entire Study Population |
|---|---|
| Mean | 26.6 ± 8.04 |
| Sex: Female, Male(Participants) | Entire Study Population |
|---|---|
| Female | 29 |
| Male | 31 |
| Region of Enrollment(participants) | Entire Study Population |
|---|---|
| United States | 60 |
No study locations are listed for this record.
The record gives a start of May 2008, a primary completion of Aug 2008 and a completion of Aug 2008. It does not say whether these dates are actual or estimated.
Results were first posted in Apr 2010, 1 year 8 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Omeprazole · Sodium Bicarbonate